On Tuesday, TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device ...
) has been revised to $2.04 / share. This is a decrease of 55.56% from the prior estimate of $4.59 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback